A statistical approach being used to support a new class of Alzheimer's drugs may lead to overstated claims about how the ...
New research reveals a statistical technique used in Alzheimer's drug trials inflates clinical efficacy claims by 29x.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results